The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Open accessAbstract
Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually. The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., respectively. These parasites have similar biology and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target. However, no such molecular targets or broad spectrum drugs have been identified to date. Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection. GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice. Our data provide genetic and chemical validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Wirtz, E., Leal, S., Ochatt, C., & Cross, G. M. (1999) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(99)00002-x · Cited by 1,423
The Genome of the Kinetoplastid Parasite, Leishmania major
Ivens, A. C., Peacock, C. S., Worthey, E. A., Murphy, L., Aggarwal, G., Berriman, M., Sisk, E., Rajandream, M.-A., Adlem, E., Aert, R., et al. (2005) · Science · doi:10.1126/science.1112680 · Cited by 1,346
Self-citationRandomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
Morillo, C. A., Marin-Neto, J. A., Avezum, A., Sosa-Estani, S., Rassi, A., Rosas, F., Villena, E., Quiroz, R., Bonilla, R., Britto, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507574 · Cited by 1,014
Comparative Genomics of Trypanosomatid Parasitic Protozoa
El-Sayed, N. M., Myler, P. J., Blandin, G., Berriman, M., Crabtree, J., Aggarwal, G., Caler, E., Renauld, H., Worthey, E. A., Hertz-Fowler, C., et al. (2005) · Science · doi:10.1126/science.1112181 · Cited by 819
Bern, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1410150 · Cited by 770
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Molina, I., Gómez i Prat, J., Salvador, F., Treviño, B., Sulleiro, E., Serre, N., Pou, D., Roure, S., Cabezos, J., Valerio, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313122 · Cited by 604
The Structure of the Mammalian 20S Proteasome at 2.75 Å Resolution
Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., & Tsukihara, T. (2002) · Structure · doi:10.1016/s0969-2126(02)00748-7 · Cited by 519
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
Kennedy, P. G. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70296-x · Cited by 442
Nunes, M. C. P., Dones, W., Morillo, C. A., Encina, J. J., & Ribeiro, A. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.046 · Cited by 386
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Nagle, A. S., Khare, S., Kumar, A. B., Supek, F., Buchynskyy, A., Mathison, C. J. N., Chennamaneni, N. K., Pendem, N., Buckner, F. S., Gelb, M. H., et al. (2014) · Chemical Reviews · doi:10.1021/cr500365f · Cited by 348
Self-citationSide effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Viotti, R., Vigliano, C., Lococo, B., Alvarez, M. G., Petti, M., Bertocchi, G., & Armenti, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.7.2.157 · Cited by 327
An update on pharmacotherapy for leishmaniasis
Sundar, S., & Chakravarty, J. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.973850 · Cited by 320
Chagas Disease Drug Discovery: Toward a New Era
Chatelain, E. (2015) · SLAS Discovery · doi:10.1177/1087057114550585 · Cited by 312
Validation of a Rapid Equilibrium Dialysis Approach for the Measurement of Plasma Protein Binding
Waters, N. J., Jones, R., Williams, G., & Sohal, B. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21317 · Cited by 310
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Li, H., O’Donoghue, A. J., van der Linden, W. A., Xie, S. C., Yoo, E., Foe, I. T., Tilley, L., Craik, C. S., da Fonseca, P. C. A., & Bogyo, M. (2016) · Nature · doi:10.1038/nature16936 · Cited by 238
GeneDB--an annotation database for pathogens
Logan-Klumpler, F. J., De Silva, N., Boehme, U., Rogers, M. B., Velarde, G., McQuillan, J. A., Carver, T., Aslett, M., Olsen, C., Subramanian, S., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1032 · Cited by 228
Bustamante, J. M., Bixby, L. M., & Tarleton, R. L. (2008) · Nature Medicine · doi:10.1038/nm1744 · Cited by 194
An efficient rapid system for profiling the cellular activities of molecular libraries
Melnick, J. S., Janes, J., Kim, S., Chang, J. Y., Sipes, D. G., Gunderson, D., Jarnes, L., Matzen, J. T., Garcia, M. E., Hood, T. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511292103 · Cited by 186
Yardley, V., & Croft, S. L. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00133-8 · Cited by 163
Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients
Dorlo, T. P. C., van Thiel, P. P. A. M., Huitema, A. D. R., Keizer, R. J., de Vries, H. J. C., Beijnen, J. H., & de Vries, P. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00014-08 · Cited by 160
Animal Models for the Analysis of Immune Responses to Leishmaniasis
Sacks, D. L., & Melby, P. C. (1998) · Current Protocols in Immunology · doi:10.1002/0471142735.im1902s28 · Cited by 135
Sacks, D. L., & Anderson, C. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00185.x · Cited by 128
The Isolation and Characterization of Murine Macrophages
Gonçalves, R., & Mosser, D. M. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s111 · Cited by 87
Effect of Noncompetitive Proteasome Inhibition on Bortezomib Resistance
Li, X., Wood, T. E., Sprangers, R., Jansen, G., Franke, N. E., Mao, X., Wang, X., Zhang, Y., Verbrugge, S. E., Adomat, H. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq198 · Cited by 80
Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery
Wang, J., & Skolnik, S. M. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900117 · Cited by 79
pTcINDEX: a stable tetracycline-regulated expression vector for Trypanosoma cruzi.
Taylor, M. C., & Kelly, J. M. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-32 · Cited by 78
Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase
McLatchie, A. P., Burrell‐Saward, H., Myburgh, E., Lewis, M. D., Ward, T. H., Mottram, J. C., Croft, S. L., Kelly, J. M., & Taylor, M. C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002571 · Cited by 76
Self-citationUtilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
Khare, S., Roach, S. L., Barnes, S. W., Hoepfner, D., Walker, J. R., Chatterjee, A. K., Neitz, R. J., Arkin, M. R., McNamara, C. W., Ballard, J., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005058 · Cited by 70
Self-citationMyburgh, E., Coles, J. A., Ritchie, R., Kennedy, P. G. E., McLatchie, A. P., Rodgers, J., Taylor, M. C., Barrett, M. P., Brewer, J. M., & Mottram, J. C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002384 · Cited by 68
Self-citationKalvass, J. C., Tess, D. A., Giragossian, C., Linhares, M. C., & Maurer, T. S. (2001) · PubMed · Cited by 66
Li, C., Liu, B., Chang, J. J., Groessl, T., Zimmerman, M., He, Y.-Q., Isbell, J. J., & Tuntland, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.004 · Cited by 61
Self-citationChemical Blockage of the Proteasome Inhibitory Function of Bortezomib
Fernández, Y., Miller, T. P., Denoyelle, C., Esteban, J. A., Tang, W., Bengston, A. L., & Soengas, M. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511607200 · Cited by 57
Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
Steverding, D., & Wang, X. (2009) · Parasites & Vectors · doi:10.1186/1756-3305-2-29 · Cited by 24
Cited by
The growing applications of SuFEx click chemistry
Barrow, A. S., Smedley, C. J., Zheng, Q., Li, S., Dong, J., & Moses, J. E. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00960k · Cited by 591
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Field, M. C., Horn, D., Fairlamb, A. H., Ferguson, M. A. J., Gray, D. W., Read, K. D., De Rycker, M., Torrie, L. S., Wyatt, P. G., Wyllie, S., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.193 · Cited by 421
An insight on medicinal attributes of 1,2,4-triazoles
Aggarwal, R., & Sumran, G. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112652 · Cited by 317
Experimental and Clinical Treatment of Chagas Disease: A Review
Sales Junior, P. A., Molina, I., Fonseca Murta, S. M., Sánchez-Montalvá, A., Salvador, F., Corrêa-Oliveira, R., & Carneiro, C. M. (2017) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0761 · Cited by 305
Chemotherapy of leishmaniasis: present challenges
ULIANA, S. R. B., TRINCONI, C. T., & COELHO, A. C. (2018) · Parasitology · doi:10.1017/s0031182016002523 · Cited by 261
Metadata
- Authors
- Khare, S., Nagle, A. S., Biggart, A., Lai, Y. H., Liang, F., Davis, L. C., Barnes, S. W., Mathison, C. J. N., Myburgh, E., Gao, M.-Y., Gillespie, J. R., Liu, X., Tan, J. L., Stinson, M., Rivera, I. C., Ballard, J., Yeh, V., Groessl, T., Federe, G., Koh, H. X. Y., Venable, J. D., Bursulaya, B., Shapiro, M., Mishra, P. K., Spraggon, G., Brock, A., Mottram, J. C., Buckner, F. S., Rao, S. P. S., Wen, B. G., Walker, J. R., Tuntland, T., Molteni, V., Glynne, R. J., & Supek, F.
- Venue
- Nature
- Published
- 2016-08-08
- Volume
- 537
- Issue
- 7619
- Pages
- 229-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2478575915
- Cited by
- 407
- References
- 34
- FWCI
- 38.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.